212 related articles for article (PubMed ID: 3720175)
1. Furosemide kinetics and dynamics in patients with cirrhosis.
Villeneuve JP; Verbeeck RK; Wilkinson GR; Branch RA
Clin Pharmacol Ther; 1986 Jul; 40(1):14-20. PubMed ID: 3720175
[TBL] [Abstract][Full Text] [Related]
2. Influence of hepatic cirrhosis and end-stage renal disease on pharmacokinetics and pharmacodynamics of furosemide.
Keller E; Hoppe-Seyler G; Mumm R; Schollmeyer P
Eur J Clin Pharmacol; 1981; 20(1):27-33. PubMed ID: 7308269
[TBL] [Abstract][Full Text] [Related]
3. Furosemide kinetics in patients with hepatic cirrhosis with ascites.
Fuller R; Hoppel C; Ingalls ST
Clin Pharmacol Ther; 1981 Oct; 30(4):461-7. PubMed ID: 7285480
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamic effects of furosemide in patients with liver cirrhosis.
Traeger A; Häntze R; Penzlin M; Krombholz B; Reinhardt M; Keil E; Jorke D
Int J Clin Pharmacol Ther Toxicol; 1985 Mar; 23(3):129-33. PubMed ID: 3997298
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of furosemide in patients with hepatic cirrhosis.
González G; Arancibia A; Rivas MI; Caro P; Antezana C
Eur J Clin Pharmacol; 1982; 22(4):315-20. PubMed ID: 7106167
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of furosemide's diuretic effect by indomethacin: pharmacokinetic evaluation.
Smith DE; Brater DC; Lin ET; Benet LZ
J Pharmacokinet Biopharm; 1979 Jun; 7(3):265-74. PubMed ID: 480148
[TBL] [Abstract][Full Text] [Related]
7. Furosemide disposition in cirrhosis.
Verbeeck RK; Patwardhan RV; Villeneuve JP; Wilkinson GR; Branch RA
Clin Pharmacol Ther; 1982 Jun; 31(6):719-25. PubMed ID: 7075120
[TBL] [Abstract][Full Text] [Related]
8. Relationship between urinary excretion rate, steady-state plasma levels and diuretic response of furosemide in the rat.
Smith DE; Benet LZ
Pharmacology; 1979; 19(6):301-6. PubMed ID: 549032
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of furosemide in advanced renal failure.
Huang CM; Atkinson AJ; Levin M; Levin NW; Quintanilla A
Clin Pharmacol Ther; 1974 Oct; 16(4):659-66. PubMed ID: 4422027
[No Abstract] [Full Text] [Related]
10. Pharmacokinetics and pharmacodynamics of torasemide and furosemide in patients with diuretic resistant ascites.
Gentilini P; La Villa G; Marra F; Carloni V; Melani L; Foschi M; Cotrozzi G; Quartini M; Chibbaro G; Tommasi AC; Bernareggi A; Simoni A; Buzzelli G; Laffi G
J Hepatol; 1996 Oct; 25(4):481-90. PubMed ID: 8912147
[TBL] [Abstract][Full Text] [Related]
11. The influence of indomethacin on the pharmacokinetics, diuretic response and hemodynamics of furosemide in the dog.
Data JL; Rane A; Gerkens J; Wilkinson GR; Nies AS; Branch RA
J Pharmacol Exp Ther; 1978 Aug; 206(2):431-8. PubMed ID: 682123
[TBL] [Abstract][Full Text] [Related]
12. Furosemide disposition in cirrhotic patients.
Sawhney VK; Gregory PB; Swezey SE; Blaschke TF
Gastroenterology; 1981 Dec; 81(6):1012-6. PubMed ID: 7286579
[TBL] [Abstract][Full Text] [Related]
13. Influence of probenecid and spironolactone on furosemide kinetics and dynamics in man.
Homeida M; Roberts C; Branch RA
Clin Pharmacol Ther; 1977 Oct; 22(4):402-9. PubMed ID: 902453
[TBL] [Abstract][Full Text] [Related]
14. [Mechanism of action of xipamide and its classification as a "low ceiling diuretic". Pharmacodynamic-pharmacokinetic studies in healthy volunteers and in kidney and liver patients].
Knauf H; Mutschler E
Arzneimittelforschung; 2005; 55(1):1-14. PubMed ID: 15727159
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of furosemide in patients with congestive heart failure.
Greither A; Goldman S; Edelen JS; Benet LZ; Cohn K
Pharmacology; 1979; 19(3):121-31. PubMed ID: 523503
[TBL] [Abstract][Full Text] [Related]
16. The pharmacokinetics and pharmacodynamics of furosemide in anesthetized dogs with normal and experimentally decreased renal function.
Miyazaki H; Hirai J; Taneike T
Nihon Juigaku Zasshi; 1990 Apr; 52(2):265-73. PubMed ID: 2348592
[TBL] [Abstract][Full Text] [Related]
17. Dose-dependent pharmacokinetics of furosemide in the rat.
Hammarlund MM; Paalzow LK
Biopharm Drug Dispos; 1982; 3(4):345-59. PubMed ID: 7159689
[TBL] [Abstract][Full Text] [Related]
18. Furosemide kinetics and dynamics after kidney transplant.
Smith DE; Gambertoglio JG; Vincenti F; Benet LZ
Clin Pharmacol Ther; 1981 Jul; 30(1):105-13. PubMed ID: 7016396
[TBL] [Abstract][Full Text] [Related]
19. Effects of the rate and composition of fluid replacement on the pharmacokinetics and pharmacodynamics of intravenous furosemide.
Li T; Lee MG; Chiou WL
J Pharmacokinet Biopharm; 1986 Oct; 14(5):495-509. PubMed ID: 3806372
[TBL] [Abstract][Full Text] [Related]
20. Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide in patients with cirrhosis.
Schwartz S; Brater DC; Pound D; Green PK; Kramer WG; Rudy D
Clin Pharmacol Ther; 1993 Jul; 54(1):90-7. PubMed ID: 8330470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
